Trial Profile
Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2015
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Embolism; Stroke
- Focus Pharmacokinetics
- 10 Nov 2015 New trial record
- 12 May 2015 Results published online in the Journal of Clinical Pharmacology.